| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52688-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81052-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81054-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52683-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52705-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44670 | |||
![Flow Cytometry: CD19 Antibody (FMC63) - Chimeric [NBP2-52688] - Flow-cytometry using anti-CD19 antibody FMC63. Human lymphocytes were stained with an isotype control (NBP2-52638, panel A) or the rabbit-chimeric version of FMC63 (NBP2-52688, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD19-Antibody-FMC63-Chimeric-Flow-Cytometry-NBP2-52688-img0001.jpg "Flow Cytometry: CD19 Antibody (FMC63) - Chimeric [NBP2-52688] - Flow-cytometry using anti-CD19 antibody FMC63. Human lymphocytes were stained with an isotype control (NBP2-52638, panel A) or the rabbit-chimeric version of FMC63 (NBP2-52688, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD30/TNFRSF8 Antibody (Ki-4) - Chimeric [NBP2-52683] - Flow-cytometry using anti-CD30 antibody Ki-4. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Ki-4 (NBP2-52683) before (B) or after anti-CD3/28 activation (C) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-Ki-4-Chimeric-Flow-Cytometry-NBP2-52683-img0001.jpg "Flow Cytometry: CD30/TNFRSF8 Antibody (Ki-4) - Chimeric [NBP2-52683] - Flow-cytometry using anti-CD30 antibody Ki-4. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Ki-4 (NBP2-52683) before (B) or after anti-CD3/28 activation (C) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Western Blot: Integrin beta 4/CD104 Antibody (M126) [NBP3-23396] - Western blot analysis of A431 cells serum starved overnight (lanes 1, 3, & 5) and treated with pervanadate (1 mM) for 30 min (lanes 2, 4, & 6). The blots were probed with rabbit polyclonal anti-Integrin beta 4/CD104 (Tyr-1526) (lanes 1 & 2) and anti-Integrin beta 4/CD104 (Tyr-1494) (lanes 3 & 4) or with mouse monoclonal anti-Integrin beta 4/CD104 (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23396_mouse-integrin-beta-4-cd104-mab-m126-19920231856926.jpg "Western Blot: Integrin beta 4/CD104 Antibody (M126) [NBP3-23396] - Western blot analysis of A431 cells serum starved overnight (lanes 1, 3, & 5) and treated with pervanadate (1 mM) for 30 min (lanes 2, 4, & 6). The blots were probed with rabbit polyclonal anti-Integrin beta 4/CD104 (Tyr-1526) (lanes 1 & 2) and anti-Integrin beta 4/CD104 (Tyr-1494) (lanes 3 & 4) or with mouse monoclonal anti-Integrin beta 4/CD104 (lanes 5 & 6).")
![Immunocytochemistry/Immunofluorescence: Integrin beta 4/CD104 Antibody (M126) [NBP3-23396] - Immunocytochemical labeling of Integrin beta 4/CD104 in control (Top) and pervanadate-treated A431 cells (Bottom). The cells were labeled with mouse monoclonal anti-Integrin beta 4/CD104 (Cytoplasmic region) (left) or rabbit polyclonals anti-Integrin beta 4/CD104 (Tyr-1494) (middle) or anti-Integrin beta 4/CD104 (Tyr-1526) (right), then the antibodies were detected using appropriate secondary antibodies conjugated to DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23396_mouse-integrin-beta-4-cd104-mab-m126-19920231992811.jpg)
![Western Blot: WASF2 [p Tyr150] Antibody [NBP3-23201] - Western blot of human K562 cells treated with pervanadate (1 mM, 30 min) (lanes 1 & 3) then treated with alkaline phosphatase (lanes 2 & 4). The blots were probed with anti-WASF2 (Central region) (lanes 1 & 2) or anti-WAVE (Tyr-150) (lanes 3 & 4).](http://images.novusbio.com/fullsize/nbp3-23201_rabbit-wasf2-p-tyr150-pab-19920231410145.jpg "Western Blot: WASF2 [p Tyr150] Antibody [NBP3-23201] - Western blot of human K562 cells treated with pervanadate (1 mM, 30 min) (lanes 1 & 3) then treated with alkaline phosphatase (lanes 2 & 4). The blots were probed with anti-WASF2 (Central region) (lanes 1 & 2) or anti-WAVE (Tyr-150) (lanes 3 & 4).")
![Immunohistochemistry-Paraffin: CD44 Antibody (CD44v6/1246) [NBP2-54572] - Formalin-paraffin human Cervical Carcinoma stained with CD44v6 Monoclonal Antibody (CD44v6/1246)](http://images.novusbio.com/fullsize/CD44-Antibody-CD44v6-1246-Immunohistochemistry-Paraffin-NBP2-54572-img0001.jpg "Immunohistochemistry-Paraffin: CD44 Antibody (CD44v6/1246) [NBP2-54572] - Formalin-paraffin human Cervical Carcinoma stained with CD44v6 Monoclonal Antibody (CD44v6/1246)")
![Immunohistochemistry-Paraffin: CD44 Antibody (CD44v6/1246) [NBP2-54572] - Formalin-paraffin human Tongue Carcinoma stained with CD44v6 Monoclonal Antibody (CD44v6/1246)](http://images.novusbio.com/fullsize/CD44-Antibody-CD44v6-1246-Immunohistochemistry-Paraffin-NBP2-54572-img0002.jpg)
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (Ki-1/1747R) [NBP2-54556] - Formalin-fixed, paraffin-embedded human Hodgkin's Lymphoma stained with CD30 Recombinant Rabbit Monoclonal Antibody (Ki-1/1747R).](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-Ki-1-1747R-Immunohistochemistry-Paraffin-NBP2-54556-img0001.jpg "Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (Ki-1/1747R) [NBP2-54556] - Formalin-fixed, paraffin-embedded human Hodgkin's Lymphoma stained with CD30 Recombinant Rabbit Monoclonal Antibody (Ki-1/1747R).")
![Immunohistochemistry-Paraffin: CD99 Antibody (MIC2/1495R) [NBP2-54373] - Formalin-fixed, paraffin-embedded human Ewing’s Sarcoma stained with CD99 Recombinant Rabbit Monoclonal Antibody (MIC2/1495R).](http://images.novusbio.com/fullsize/CD99-Antibody-MIC2-1495R-Immunohistochemistry-Paraffin-NBP2-54373-img0001.jpg "Immunohistochemistry-Paraffin: CD99 Antibody (MIC2/1495R) [NBP2-54373] - Formalin-fixed, paraffin-embedded human Ewing’s Sarcoma stained with CD99 Recombinant Rabbit Monoclonal Antibody (MIC2/1495R).")
![Flow Cytometry: CD46 Antibody (122.2) - Azide and BSA Free [NBP2-33159] - FCM staining of human PBMCs using CD46 Antibody (122.2).](http://images.novusbio.com/fullsize/CD46-Antibody-122-2-Azide-and-BSA-Free-Flow-Cytometry-NBP2-33159-img0001.jpg "Flow Cytometry: CD46 Antibody (122.2) - Azide and BSA Free [NBP2-33159] - FCM staining of human PBMCs using CD46 Antibody (122.2).")